Grant Chamberlain


LLB(Hons), BCom


Grant Chamberlain - Principal at OneVentures, leading Australian Venture Capital firm


Sydney, AU

Current board roles

Immutep Limited (ASX IMM; NASDAQ IMPP)



Prior to joining OneVentures as Principal, Grant Chamberlain was Australian Head of Mergers & Acquisitions and Financial Sponsors for Bank of America Merrill Lynch.

He has over twenty years’ experience in Australian and cross border mergers and acquisitions, joint ventures and capital markets at global investment banks Bank of America Merrill Lynch, Deutsche Bank and Nomura and has a broad range of experience across industries including technology, healthcare, consumer goods, financial services and natural resources.

Grant has led many of the largest and most complex transactions in Australia in recent years including Woodside’s offer for Oil Search, Iron Mountain’s acquisition of Recall, CSC’s acquisition of UXC, Wilmar and First Pacific’s acquisition of Goodman Fielder, Dai-ichi Life’s acquisition of Tower Australia, Kirin’s acquisition of Lion Nathan, Cephalon’s acquisition of Arana Therapeutics and its investment in Mesoblast, Foster’s acquisition of Southcorp and Webcentral’s merger with Melbourne IT.

Grant currently serves as non-executive director and member of the audit and remuneration committees of Immutep Limited, an ASX and NASDAQ listed immuno-oncology research company.

He holds an LLB (Hons) and B.Com from the University of Melbourne.